GLP-1 medications like Ozempic, Wegovy, and Mounjaro have revolutionized diabetes management and weight loss for millions of Americans
Food and Drug Administration (FDA) has approved four GLP-1 drugs for weight loss in people with overweight or obesity: liraglutide (Saxenda) orforglipron (Foundayo) semaglutide (Wegovy) tirzepatide (Zepound) Liraglutide, semaglutide, and tirzepatide are injectable medications that come in prefilled pens
Follow-up visits typically occur every 2 to 4 weeks to track your progress, adjust your treatment as needed, and offer continued support
When combined with lifestyle changes, medical guidance, and ongoing support, these therapies can help patients make sustainable progress toward their health goals
GLP-1 patches are OTC (over-the-counter) transdermal patches that claim to deliver GLP-1 drugs through the skin
Not Patients seeking doctor-led care or full medical screening may find the intake too light